Targeting Gut Disease (TGD) S.r.l. is a young and dynamic SME, highly specialized in the development of anti-inflammatory
supplements of natural origin. The fusion of entrepreneurial spirit, scientific distinction and internationally recognized clinical expertise is our key asset and the pillars on which we will stand to gain a leading position in the globally rising market of nutraceutical products.
TGD was born in 2015 from the will of its members to apply their extensive and know-how into a range of commercial products for cost-effective and reliable management of chronic inflammatory conditions of the gastrointestinal tract. This spin-off from the University of Bologna, due to the qualified interdisciplinary skills of its team, is able to cover the whole process in the elaboration of new dietary products, from the in vitro research up to the clinical validation.